# GeneDx to Participate in 44th Annual Cowen Health Care Conference
Canonical URL: https://biopharmsignal.com/news/WGS/genedx-to-participate-in-44th-annual-cowen-health-care-conference-65328beb
Ticker: WGS
Company: GeneDx
Source: GeneDx
Published: 2024-02-26 21:05 EST
## Summary

GeneDx (Nasdaq: WGS) today announced that company management will participate in the Cowen Healthcare Conference from March 4-6 in Boston, MA. ...

## Article Body
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that company management will participate in the Cowen Healthcare Conference from March 4-6 in Boston, MA. Management will participate in a fireside chat on Wednesday, March 6, 2024, at 10:30 a.m. ET.

A live and archived webcast of the presentation will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.

About GeneDx At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit www.genedx.com and connect with us on LinkedIn , Facebook , Twitter and Instagram.

GeneDx Investor Relations Contact: Investors@GeneDx.com

GeneDx Media Contact: Press@GeneDx.com
## Recent Company News
- 2024-07-11 20:05 EST — [GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024](https://biopharmsignal.com/news/WGS/genedx-to-report-second-quarter-2024-financial-results-on-tuesday-july-30-2024-4818bc73) — Source: GeneDx
- 2024-06-10 12:30 EST — [GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients](https://biopharmsignal.com/news/WGS/genedx-announces-collaboration-with-epic-aura-to-expand-access-to-rapid-whole-ge-740de912) — Source: GeneDx
- 2024-06-05 11:00 EST — [GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients](https://biopharmsignal.com/news/WGS/genedx-announces-patient-access-program-to-expand-access-to-exome-testing-for-pe-c4b289d2) — Source: GeneDx
- 2024-05-22 20:05 EST — [GeneDx to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/WGS/genedx-to-participate-in-upcoming-investor-conferences-5e6d9364) — Source: GeneDx
- 2024-04-29 20:05 EST — [GeneDx Reports First Quarter 2024 Financial Results and Business Highlights](https://biopharmsignal.com/news/WGS/genedx-reports-first-quarter-2024-financial-results-and-business-highlights-6b87f4af) — Source: GeneDx
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)